![Andreas Wicki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Wicki
Vorstandsvorsitzender bei
HBM HEALTHCARE INVESTMENTS AG
Vermögen: 14 Mio $ am 31.05.2026
Profil
Dr. Andreas Wicki is an Independent Director at Harmony Biosciences Holdings, Inc., a Chief Executive Officer at HBM Partners AG, a Chief Executive Officer at HBM Partners AG, a Chief Executive Officer at HBM Healthcare Investments AG and a Chief Executive Officer & Director at HBM Healthcare Investments (Cayman) Ltd. He is on the Board of Directors at Harmony Biosciences Holdings, Inc., HBM BioPharma India Ltd., HBM Biocapital Ltd., HBM Healthcare Investments (Cayman) Ltd., HBM BioVentures (Cayman) Ltd., Buchler GmbH, Harmony Biosciences LLC, MDS Pharma Services Switzerland AG and Vitaeris, Inc. He has successful healthcare entrepreneur and investor with over 30 years of experience in the pharmaceutical and biotechnology industries.
Dr. Wicki was previously co-owner and CEO of ANAWA Holding AG and Clinserve AG, two Contract Research Organisations specialising in analytical services.
Board member of Harmony Biosciences, HBM Healthcare Investments (Cayman) Ltd. and Buchler (FAGUS Group).
He received MSc and PhD in chemistry and biochemistry from the University of Berne, Switzerland.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2025 | 44 707 ( 0,66 % ) | 14 Mio $ | 31.05.2026 |
Aktive Positionen von Andreas Wicki
| Unternehmen | Position | Beginn |
|---|---|---|
| HBM HEALTHCARE INVESTMENTS AG | Vorstandsvorsitzender | 20.02.2012 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Direktor/Vorstandsmitglied | 01.09.2017 |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Vorstandsvorsitzender | 02.01.2004 |
HBM Biocapital Ltd.
 HBM Biocapital Ltd. Financial ConglomeratesFinance Provides investment services | Direktor/Vorstandsmitglied | 01.01.2004 |
Buchler GmbH
 Buchler GmbH Chemicals: SpecialtyProcess Industries Manufactures enantiomers for the pharmaceutical, chemical and beverage industries | Direktor/Vorstandsmitglied | 01.01.2000 |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Direktor/Vorstandsmitglied | - |
Vitaeris, Inc.
 Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Direktor/Vorstandsmitglied | - |
HBM Healthcare Investments (Cayman) Ltd.
 HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Provides healthcare services | Vorstandsvorsitzender | 01.01.2001 |
HBM Partners AG (Investment Management)
 HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs. | Vorstandsvorsitzender | 02.01.2004 |
| ░░░ ░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ehemalige bekannte Positionen von Andreas Wicki
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Andreas Wicki
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
68
Beziehungen ersten Grades
21
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 21 |
|---|---|
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Medical SpecialtiesHealth Technology Provides cobalt-60 and gamma irradiation system services for the medical device, food safety & health care industries | Health Technology |
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Finance |
HBM BioVentures (Cayman) Ltd.
 HBM BioVentures (Cayman) Ltd. Financial ConglomeratesFinance Acquisition vehicle | Finance |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
Clinserve Laboratories
 Clinserve Laboratories Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
HBM Healthcare Investments AG
 HBM Healthcare Investments AG Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Basilea Pharmaceutica AG
 Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Bern
 University of Bern Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HBM Biocapital Ltd.
HBM Biocapital Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
PharmaSwiss SA
 PharmaSwiss SA Medical DistributorsDistribution Services Provides distribution, marketing, sales and licensing services for pharmaceutical products | Distribution Services |
Buchler GmbH
Buchler GmbH Chemicals: SpecialtyProcess Industries Manufactures enantiomers for the pharmaceutical, chemical and beverage industries | Process Industries |
MDS Pharma Services Switzerland AG | |
HBM BioPharma India Ltd.
 HBM BioPharma India Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Anawa Laboratorien AG | |
MDS (US), Inc. | Health Technology |
HBM Healthcare Investments (Cayman) Ltd.
HBM Healthcare Investments (Cayman) Ltd. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
HBM Partners AG (Investment Management)
HBM Partners AG (Investment Management) Investment ManagersFinance HBM-IM invests in biopharma and other healthcare-related companies across Europe, North America, India and other Emerging Markets. Their main fund, HBM Healthcare Investments, invests in private and public companies and IPOs. | Finance |
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Health Technology |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Harmony Biosciences LLC
Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for people living with rare neurological disorders | Health Technology |
Viela Bio, Inc.
 Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
